{"protocolSection":{"identificationModule":{"nctId":"NCT00605085","orgStudyIdInfo":{"id":"IC51-302"},"organization":{"fullName":"Valneva Austria GmbH","class":"INDUSTRY"},"briefTitle":"Safety and Tolerability of the Japanese Encephalitis Vaccine IC51","officialTitle":"Safety and Tolerability of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Placebo Controlled Phase 3 Study"},"statusModule":{"statusVerifiedDate":"2024-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2005-10"},"completionDateStruct":{"date":"2006-11","type":"ACTUAL"},"studyFirstSubmitDate":"2008-01-04","studyFirstSubmitQcDate":"2008-01-16","studyFirstPostDateStruct":{"date":"2008-01-30","type":"ESTIMATED"},"resultsFirstSubmitDate":"2012-06-01","resultsFirstSubmitQcDate":"2012-10-19","resultsFirstPostDateStruct":{"date":"2012-11-20","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-03-20","lastUpdatePostDateStruct":{"date":"2024-03-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldOrganization":"Intercell AG"},"leadSponsor":{"name":"Valneva Austria GmbH","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The objective is to investigate the safety and tolerability of Japanese Encephalitis vaccine IC51 with an inactive control in healthy subjects aged \\> or = 18 years"},"conditionsModule":{"conditions":["Japanese Encephalitis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":2675,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"1","type":"EXPERIMENTAL","description":"IC51","interventionNames":["Biological: Japanese Encephalitis purified inactivated vaccine (IC51)"]},{"label":"2","type":"PLACEBO_COMPARATOR","description":"Placebo","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Japanese Encephalitis purified inactivated vaccine (IC51)","description":"IC51 (JE-PIV), 6 mcg, i.m. injection, 2 vaccinations, days 0 and 28","armGroupLabels":["1"]},{"type":"BIOLOGICAL","name":"Placebo","description":"Placebo: Phosphate-buffered saline (PBS) solution containing 0.1% aluminum hydroxide as an adjuvant, 0.5 mL, i.m. injection, 2 injections, days 0 and 28","armGroupLabels":["2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Safety and Tolerability up to Day 56","description":"calculation based on safety population, numbers provide percentages of participants with Adverse Events (AEs)","timeFrame":"Day 56"}],"secondaryOutcomes":[{"measure":"Rates of Serious Adverse Events and Medically Attended Adverse Events","timeFrame":"until Day 56"},{"measure":"Changes in Laboratory Parameters","timeFrame":"until Day 56"},{"measure":"SCR and GMT of Subjects With Concomitant Vaccinations","timeFrame":"until Day 56"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* At least 18 years of age\n* Written informed consent obtained prior to study entry\n\nExclusion Criteria:\n\n* Use of any other investigational or non-registered drug or vaccine in addition to the study vaccine during the study period or within 30 days preceding the first dose of study vaccine\n* History of any previous JE vaccination (e.g. JE-VAX®)\n* Immunodeficiency including post-organ-transplantation or immunosuppressive therapy\n* A family history of congenital or hereditary immunodeficiency\n* History of autoimmune disease\n* Any acute infections within 2 weeks prior to enrollment\n* Known or suspected HIV Infection\n* Pregnancy, lactation or unreliable contraception in female subjects","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Astrid Kaltenboeck, Ph.D.","affiliation":"Valneva Austria GmbH","role":"STUDY_DIRECTOR"}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"IC51","description":"IC51"},{"id":"FG001","title":"Placebo","description":"Placebo"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"2012"},{"groupId":"FG001","numSubjects":"663"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1962"},{"groupId":"FG001","numSubjects":"638"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"50"},{"groupId":"FG001","numSubjects":"25"}]}],"dropWithdraws":[{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"5"}]},{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"5"}]},{"type":"Pregnancy","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"5"}]},{"type":"administrative reasons","reasons":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"8"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"IC51","description":"IC51"},{"id":"BG001","title":"Placebo","description":"Placebo"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"1993"},{"groupId":"BG001","value":"657"},{"groupId":"BG002","value":"2650"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"33.9","spread":"13.3"},{"groupId":"BG001","value":"33.4","spread":"13"},{"groupId":"BG002","value":"33.8","spread":"13.2"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"1088"},{"groupId":"BG001","value":"378"},{"groupId":"BG002","value":"1466"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"905"},{"groupId":"BG001","value":"279"},{"groupId":"BG002","value":"1184"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"Australia","categories":[{"measurements":[{"groupId":"BG000","value":"294"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"394"}]}]},{"title":"Europe","categories":[{"measurements":[{"groupId":"BG000","value":"1236"},{"groupId":"BG001","value":"406"},{"groupId":"BG002","value":"1642"}]}]},{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"463"},{"groupId":"BG001","value":"151"},{"groupId":"BG002","value":"614"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Safety and Tolerability up to Day 56","description":"calculation based on safety population, numbers provide percentages of participants with Adverse Events (AEs)","populationDescription":"Safety Population","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"percentage of participants with AEs","timeFrame":"Day 56","groups":[{"id":"OG000","title":"IC51","description":"IC51"},{"id":"OG001","title":"Placebo","description":"Placebo"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1993"},{"groupId":"OG001","value":"657"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58.9"},{"groupId":"OG001","value":"56.6"}]}]}]},{"type":"SECONDARY","title":"Rates of Serious Adverse Events and Medically Attended Adverse Events","reportingStatus":"NOT_POSTED","timeFrame":"until Day 56","denomUnitsSelected":"Participants"},{"type":"SECONDARY","title":"Changes in Laboratory Parameters","reportingStatus":"NOT_POSTED","timeFrame":"until Day 56","denomUnitsSelected":"Participants"},{"type":"SECONDARY","title":"SCR and GMT of Subjects With Concomitant Vaccinations","reportingStatus":"NOT_POSTED","timeFrame":"until Day 56","denomUnitsSelected":"Participants"}]},"adverseEventsModule":{"frequencyThreshold":"2","description":"Safet population (N = 2650): All subjects who entered the study and received at least one vaccination. All analyses based on the safety population were carried out using the actual treatment received.\n\nThe safety population was used for all safety and tolerability analyses and for the analysis of demographic and background data.","eventGroups":[{"id":"EG000","title":"IC51","description":"IC51","seriousNumAffected":10,"seriousNumAtRisk":1993,"otherNumAffected":917,"otherNumAtRisk":1993},{"id":"EG001","title":"Placebo","description":"Placebo","seriousNumAffected":6,"seriousNumAtRisk":657,"otherNumAffected":292,"otherNumAtRisk":657}],"seriousEvents":[{"term":"Acute Coronary Syndrome","organSystem":"Cardiac disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1993},{"groupId":"EG001","numAffected":1,"numAtRisk":657}]},{"term":"Proctalgia","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1993},{"groupId":"EG001","numAffected":1,"numAtRisk":657}]},{"term":"Rectal Haemorrhage","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Chest Pain","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Abscess Limb","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Appendicitis","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":2,"numAtRisk":657}]},{"term":"Face Injury","organSystem":"Injury, poisoning and procedural complications","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Facial Bones Fracture","organSystem":"Injury, poisoning and procedural complications","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Ulna Fracture","organSystem":"Injury, poisoning and procedural complications","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Calculus Urinary","organSystem":"Renal and urinary disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1993},{"groupId":"EG001","numAffected":1,"numAtRisk":657}]},{"term":"Adnexa Uteri Pain","organSystem":"Reproductive system and breast disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Ovarian Cyst Ruptured","organSystem":"Reproductive system and breast disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Ovarian Torsion","organSystem":"Reproductive system and breast disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Dermatomyositis","organSystem":"Skin and subcutaneous tissue disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":1993},{"groupId":"EG001","numAffected":0,"numAtRisk":657}]},{"term":"Curculatory Collapse","organSystem":"Vascular disorders","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":1993},{"groupId":"EG001","numAffected":1,"numAtRisk":657}]}],"otherEvents":[{"term":"Nausea","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":131,"numAtRisk":1993},{"groupId":"EG001","numAffected":49,"numAtRisk":657}]},{"term":"Fatigue","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":227,"numAtRisk":1993},{"groupId":"EG001","numAffected":77,"numAtRisk":657}]},{"term":"Influenza Like Illness","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":248,"numAtRisk":1993},{"groupId":"EG001","numAffected":78,"numAtRisk":657}]},{"term":"Pyrexia","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":64,"numAtRisk":1993},{"groupId":"EG001","numAffected":20,"numAtRisk":657}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":94,"numAtRisk":1993},{"groupId":"EG001","numAffected":26,"numAtRisk":657}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","stats":[{"groupId":"EG000","numAffected":311,"numAtRisk":1993},{"groupId":"EG001","numAffected":102,"numAtRisk":657}]},{"term":"Headache","organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numAffected":559,"numAtRisk":1993},{"groupId":"EG001","numAffected":173,"numAtRisk":657}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"title":"Senior Manager Clinical Research","organization":"Intercell AG","email":"kdubischar-kastner@intercell.com","phone":"+43 1 206 20","phoneExt":"1175"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D004672","term":"Encephalitis, Japanese"}],"ancestors":[{"id":"D004671","term":"Encephalitis, Arbovirus"},{"id":"D018792","term":"Encephalitis, Viral"},{"id":"D020805","term":"Central Nervous System Viral Diseases"},{"id":"D002494","term":"Central Nervous System Infections"},{"id":"D007239","term":"Infections"},{"id":"D000069544","term":"Infectious Encephalitis"},{"id":"D001102","term":"Arbovirus Infections"},{"id":"D000079426","term":"Vector Borne Diseases"},{"id":"D000096724","term":"Mosquito-Borne Diseases"},{"id":"D014777","term":"Virus Diseases"},{"id":"D012327","term":"RNA Virus Infections"},{"id":"D018177","term":"Flavivirus Infections"},{"id":"D018178","term":"Flaviviridae Infections"},{"id":"D004660","term":"Encephalitis"},{"id":"D001927","term":"Brain Diseases"},{"id":"D002493","term":"Central Nervous System Diseases"},{"id":"D009422","term":"Nervous System Diseases"},{"id":"D000090862","term":"Neuroinflammatory Diseases"}]}},"hasResults":true}